Comparison between tadalafil 5 mg vs. Serenoa repens/selenium/lycopene for the treatment of benign prostatic lower urinary tract symptoms secondary to benign prostatic hyperplasia. A phase IV, randomized, multicenter, non-inferiority clinical study. SPRITE study

Autor:	S. Voce, Antonella Giannantoni, C. Terrone, V. Beatrici, P. La Rosa, Marco Carini, P. Polledro, F. Santaniello, Giovanna Russo, M. Bitelli, Rosaria M. Pareo, Massimo Madonia, Marcello Gentile, Giuseppe Vespasiani, A. Ginepri, Giuseppe Morgia, M. Di Mauro, Giulio Reale, P. Veneziano, P. Fedelini, Salvatore Arnone, G. Salvia, Franco Blefari, G. Santelli
Rok vydání:	2017
Předmět:	Gynecology medicine.medical_specialty business.industry Urology chemistry.chemical_element Serenoa repens Hyperplasia medicine.disease Lycopene Tadalafil Clinical study chemistry.chemical_compound Non inferiority chemistry Lower urinary tract symptoms medicine business Selenium medicine.drug
Zdroj:	European Urology Supplements. 16:e926-e927
ISSN:	1569-9056
DOI:	10.1016/s1569-9056(17)30593-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::eb095a3660a3cd11cf38449813e62653 https://doi.org/10.1016/s1569-9056(17)30593-6 Zobrazit plný text záznamu Full Text from ScienceDirect